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Sample collection
Sample processing and storage by both providers were similar except for how whole blood was clotted and centrifuged to obtain serum (room temperature for Valley Biomedical Products and Services versus 4 °C for Bioreclamation LLC). Briefly Blood was allowed to clot overnight at 4 °C (Bioreclamation) or at room temperature (Valley Biomedical Products and Services). The following day the serum is centrifuged, collected, and stored at -20 °C.
The validation set (n = 90) which included samples from both providers, 60 samples from Valley Biomedical Products and Services and 30 samples from Bioreclamation LLC was evaluated for whether differences in anti-glycan antibody signals due to possible differences in how the samples were collected. To assess the comparability of data obtained for serum from both providers, the average IgG and IgM intensities for each glycan in the array were calculated from each provider. The average IgG and IgM antibody signals were similar from both providers ( Figure S5 ). The data suggests that sample collection and handling by the two providers in this study have minimal effect on anti-glycan antibody levels. Figure S6 . Representative examples of pre-and post-experimental array images. Signals in the Pre-experiment images are due to inclusion of a soluble fluorescent dye in the print buffer (the free acid of DyLight 649), which is washed away during blocking tp. Blue boxes indicate spots that were printed from empty wells, and pink boxes indicate spots that were missing during printing of the arrays.
